RE: I'm out14 Jan 2022 23:15
Agreed poorinvestor
The price range over the last 3 years is 2p - 15p (5 yrs 2p- 35p) and we are right near the bottom of the range.
N4 are Looking to pursue gene therapy and oncology , the have an existing MTA with a global gene therapy player whilst being in ADVANCED discussions with a 3rd MTA. Not forgetting the recent promising oncology results.
That 3 yr price range combined with the above tells me that at some point in the future the SP will be skewed to the upside here.
Of course no one should bet the house on it as nothing is guaranteed but IMO it’s a good bet if sized accordingly. DYOR.